WESTBOURNE INVESTMENTS, INC.

Position in EXEL — Exelixis, Inc.

CIK 932929 ALEXANDRIA, VA

Position in EXEL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,269,113

+$938,513 QoQ

Shares Held

23,325

+211.0% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

#310

of 751 holders

Holding Since

Jun 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WESTBOURNE INVESTMENTS, INC. holds $3,994,151 across 4 Biotechnology names. EXEL ranks #1 (31.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc. This page	23,325	$1,269,113
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,506	$1,244,805
3	JAZZ	Jazz Pharmaceuticals plc	4,849	$1,168,463
4	REGN	Regeneron Pharmaceuticals, Inc.	500	$311,770

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,269,113	23,325	+211.0%	Shares	Sole	2026-08-11
2025-06-30	$330,600	7,500	—	Shares	Sole	2025-07-09
No filing history on record for this holder in this stock.